Literature DB >> 27966949

Profiling Prediction of Kinase Inhibitors: Toward the Virtual Assay.

Benjamin Merget1, Samo Turk1, Sameh Eid1, Friedrich Rippmann2, Simone Fulle1.   

Abstract

Kinome-wide screening would have the advantage of providing structure-activity relationships against hundreds of targets simultaneously. Here, we report the generation of ligand-based activity prediction models for over 280 kinases by employing Machine Learning methods on an extensive data set of proprietary bioactivity data combined with open data. High quality (AUC > 0.7) was achieved for ∼200 kinases by (1) combining open with proprietary data, (2) choosing Random Forest over alternative tested Machine Learning methods, and (3) balancing the training data sets. Tests on left-out and external data indicate a high value for virtual screening projects. Importantly, the derived models are evenly distributed across the kinome tree, allowing reliable profiling prediction for all kinase branches. The prediction quality was further improved by employing experimental bioactivity fingerprints of a small kinase subset. Overall, the generated models can support various hit identification tasks, including virtual screening, compound repurposing, and the detection of potential off-targets.

Mesh:

Substances:

Year:  2016        PMID: 27966949     DOI: 10.1021/acs.jmedchem.6b01611

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

Review 1.  Kinase inhibitors: the road ahead.

Authors:  Fleur M Ferguson; Nathanael S Gray
Journal:  Nat Rev Drug Discov       Date:  2018-03-16       Impact factor: 84.694

2.  Target-specific compound selectivity for multi-target drug discovery and repurposing.

Authors:  Tianduanyi Wang; Otto I Pulkkinen; Tero Aittokallio
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988

3.  Exploring kinase family inhibitors and their moiety preferences using deep SHapley additive exPlanations.

Authors:  You-Wei Fan; Wan-Hsin Liu; Yun-Ti Chen; Yen-Chao Hsu; Nikhil Pathak; Yu-Wei Huang; Jinn-Moon Yang
Journal:  BMC Bioinformatics       Date:  2022-06-20       Impact factor: 3.307

4.  Improving the Prediction of Potential Kinase Inhibitors with Feature Learning on Multisource Knowledge.

Authors:  Yichen Zhong; Cong Shen; Huanhuan Wu; Tao Xu; Lingyun Luo
Journal:  Interdiscip Sci       Date:  2022-05-10       Impact factor: 3.492

5.  Multi-objective de novo drug design with conditional graph generative model.

Authors:  Yibo Li; Liangren Zhang; Zhenming Liu
Journal:  J Cheminform       Date:  2018-07-24       Impact factor: 5.514

6.  S2DV: converting SMILES to a drug vector for predicting the activity of anti-HBV small molecules.

Authors:  Jinsong Shao; Qineng Gong; Zeyu Yin; Wenjie Pan; Sanjeevi Pandiyan; Li Wang
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

7.  Facing small and biased data dilemma in drug discovery with enhanced federated learning approaches.

Authors:  Zhaoping Xiong; Ziqiang Cheng; Xinyuan Lin; Chi Xu; Xiaohong Liu; Dingyan Wang; Xiaomin Luo; Yong Zhang; Hualiang Jiang; Nan Qiao; Mingyue Zheng
Journal:  Sci China Life Sci       Date:  2021-07-26       Impact factor: 6.038

Review 8.  Artificial intelligence to deep learning: machine intelligence approach for drug discovery.

Authors:  Rohan Gupta; Devesh Srivastava; Mehar Sahu; Swati Tiwari; Rashmi K Ambasta; Pravir Kumar
Journal:  Mol Divers       Date:  2021-04-12       Impact factor: 3.364

9.  Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors.

Authors:  Anna Cichonska; Balaguru Ravikumar; Elina Parri; Sanna Timonen; Tapio Pahikkala; Antti Airola; Krister Wennerberg; Juho Rousu; Tero Aittokallio
Journal:  PLoS Comput Biol       Date:  2017-08-07       Impact factor: 4.475

Review 10.  Recent advances in drug repurposing using machine learning.

Authors:  Fabio Urbina; Ana C Puhl; Sean Ekins
Journal:  Curr Opin Chem Biol       Date:  2021-07-16       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.